ClinicalTrials.Veeva

Menu

The Effect of a Low FODMAP Diet in Irritable Bowel Syndrome Patients (FIBS)

U

Universitaire Ziekenhuizen KU Leuven

Status

Unknown

Conditions

Irritable Bowel Syndrome
FODMAP

Treatments

Other: low FODMAP diet

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Tertiary care IBS patients will be recruited for a prospective low FODMAP intervention study, hereby focusing on the reintroduction phase of the diet, where patients are blindly challenged with different FODMAP groups administered as powder, to be added to the strict FODMAP exclusion phase. During the screening phase of two weeks, baseline data regarding psychological, nutritional, microbial, and genetics will be collected. Predictors of treatment response (a 50-point drop on the IBS-severity scoring system (IBS-SSS) during the strict FODMAP exclusion phase of 6 weeks) will be studied with linear mixed models.

Enrollment

45 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients are eligible for the study if all of the following criteria are met:

    1. Patients with irritable bowel syndrome as per Rome IV diagnostic criteria
  • Symptom characteristics of IBS according to Rome IV criteria 2. Patients must provide witnessed written informed consent prior to any study procedures being performed 3. Patients aged between 18 and 70 years inclusive 4. Male or female patients

Exclusion criteria

  • Patients are excluded from the study if any of the following criteria are met:

    1. Patients with any condition which, in the opinion of the investigator, makes the patient unsuitable for entry into the study
    2. Patients with any major psychiatric disorders (including those with a major psychosomatic element to their gastrointestinal disease), depression, alcohol or substance abuse in the last 2 years
    3. Patients presenting with predominant symptoms of functional dyspepsia (FD) and of gastro-oesophageal reflux disease (GERD)
    4. Patients who changed their diet over the last 3 months or have previously tried the low FODMAP diet are excluded from the study.
    5. Females who are pregnant or lactating are excluded from the study.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

45 participants in 1 patient group

low FODMAP diet
Experimental group
Treatment:
Other: low FODMAP diet

Trial contacts and locations

1

Loading...

Central trial contact

Jan Tack, professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems